Mohd Hanafiah K,Groeger J,Flaxman AD,Wiersma ST .2013 .Global epidemiology of hepatitis C virus infection: New estimates of agespecific antibody to HCV seroprevalence. Hepatology, 57(4) : 1333-42.
Ott J,Stevens G,Groeger J,Wiersma S. .2012 .Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine, 30(12) : 2212-9.
Lavanchy D. .2011 .Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection, 17(2) : 107-15.
van de Laar TJ,Matthews GV,Prins M,Danta M. .2010 .Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection. Aids, 24(12) : 1799-812.
Singal AK,Singh A,Jaganmohan S,Guturu P,Mummadi R,Kuo YF .2010 .Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clinical Gastroenterology and Hepatology, 8(2) : 192-9.
Westbrook RH,Dusheiko G .2014 .Natural history of hepatitis C. Journal of hepatology, 61(1) : S58-S68.
Rindali L,Di Francia R,Coppola N,Guerrera B,Imparato M,Monari C .2016 .Hepatocellular carcinoma in HCV cirrhosis after viral clearance with direct acting antiviral therapy: preliminary evidence and possible meanings. World Canc Res J, 3(3) : e748.
Conti F,Buonfiglioli F,Scuteri A,Crespi C,Bolondi L,Caraceni P .2016 .Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Journal of hepatology, 65(4) : 727-33.
Gramenzi A,Andreone P,Fiorino S,Camma C,Giunta M,Magalotti D .2001 .Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis. Gut, 48(6) : 843-8.
Yu M,Lin S-M W-L,Dai C-Y,Wang J-H,Lu S-N J-H .2006 .A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antiviral therapy, 11(8) : 985.
Blonski W,Reddy KR .2008 .Hepatitis C virus infection and hepatocellular carcinoma. Clinics in liver disease, 12(3) : 661-74.
Liu CJ .2014 .Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues. Journal of gastroenterology and hepatology, 29(1) : 26-30.
Huang C-F M-L,Huang C-I,Lin Y-J,Tsai P-C Lin Z-Y .2017 .Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance. Oncotarget, 8(27) : 43925.
Hoshida Y,Fuchs BC,Bardeesy N,Baumert TF,Chung RT .2014 .Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. Journal of hepatology, 61(1) : S79-S90.
Huang ,Jen C-L,Yang H-I,Lee M-H,Su J,Lu S-N .2011 .Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. Journal of Clinical Oncology, 29(27) : 3643-50.